Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126188352 | 12618835 | 2 | F | 201605 | 20160822 | 20160803 | 20160830 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-47182BP | BOEHRINGER INGELHEIM | 81.70 | YR | F | Y | 0.00000 | 20160830 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126188352 | 12618835 | 1 | PS | ATROVENT | IPRATROPIUM BROMIDE | 1 | Respiratory (inhalation) | 4 ANZ | 150368W | 21527 | NEBULISER LIQUID | BID | |||||||
| 126188352 | 12618835 | 2 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 5 MG | 0 | 5 | MG | TABLET | QD | ||||||
| 126188352 | 12618835 | 3 | C | TIKOSYN | DOFETILIDE | 1 | Oral | 500 MCG | 0 | 250 | UG | TABLET | BID | ||||||
| 126188352 | 12618835 | 4 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 100 MG | 0 | 50 | MG | TABLET | BID | ||||||
| 126188352 | 12618835 | 5 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 80 MG | 0 | 40 | MG | TABLET | BID | ||||||
| 126188352 | 12618835 | 6 | C | Calcium | CALCIUM | 1 | Oral | 1000 MG | 0 | 500 | MG | TABLET | BID | ||||||
| 126188352 | 12618835 | 7 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG | 0 | 20 | MG | CAPSULE | BID | ||||||
| 126188352 | 12618835 | 8 | C | Pataday ophthalmic solution | 2 | Unknown | 1 ANZ | 0 | ORAL DROPS | QD | |||||||||
| 126188352 | 12618835 | 9 | C | Pataday ophthalmic solution | 2 | 0 | |||||||||||||
| 126188352 | 12618835 | 10 | C | Pataday ophthalmic solution | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126188352 | 12618835 | 1 | Mycobacterium avium complex infection |
| 126188352 | 12618835 | 2 | Hypertension |
| 126188352 | 12618835 | 3 | Product used for unknown indication |
| 126188352 | 12618835 | 4 | Hypertension |
| 126188352 | 12618835 | 5 | Hypertension |
| 126188352 | 12618835 | 6 | Product used for unknown indication |
| 126188352 | 12618835 | 7 | Gastrooesophageal reflux disease |
| 126188352 | 12618835 | 8 | Macular degeneration |
| 126188352 | 12618835 | 9 | Glaucoma |
| 126188352 | 12618835 | 10 | Cataract |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126188352 | 12618835 | Drug ineffective | |
| 126188352 | 12618835 | Off label use | |
| 126188352 | 12618835 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126188352 | 12618835 | 1 | 201605 | 0 |